Sagimet Biosciences Inc. (SGMT) Tops Q2 EPS by 25c

Sagimet Biosciences Inc. (NASDAQ: SGMT) reported Q2 EPS of ($0.25), $0.25 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Sagimet Biosciences Inc. (SGMT) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
• Wendy's U.S. president to resign, company to create COO role